Agamed Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Agamed Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals

Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | All Other Miscellaneous Schools and Instruction | Ambulatory Health Care Services | Offices of Physicians | Freestanding Ambulatory Surgical and Emergency Centers | All Other Miscellaneous Ambulatory Health Care Services

Full name: Agamed Sp. z o.o.

Profile Updated: June 01, 2024

Agamed Sp. z o.o. is based in Poland, with the head office in Lodz. It operates in the General Medical and Surgical Hospitals sector. It was incorporated on October 29, 2019. There was a net sales revenue increase of 35.34% reported in Agamed Sp. z o.o.’s latest financial highlights for 2023. There was a total negative growth of 3.65% in Agamed Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Traugutta 8/10
Lodz; Lodzkie; Postal Code: 90-107

Contact Details: Purchase the Agamed Sp. z o.o. report to view the information.

Website: http://www.agamed.pl

Basic Information

Outstanding Shares:

Purchase the Agamed Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Agamed Sp. z o.o. report to view the information.

Incorporation Date:

October 29, 2019

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Management Board Member

Ownership Details

Purchase this report to view the information.

96%

Company Performance

Financial values in the chart are available after Agamed Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

35.34%▲

Total operating revenue

35.4%▲

Operating profit (EBIT)

N/A

EBITDA

-95.71%▼

Net Profit (Loss) for the Period

N/A

Total assets

-3.65%▼

Total equity

-10.05%▼

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Quick Ratio

-0.64%▼

Similar companies